The Feasibility and Applicability of Pediatric Inpatient Beta Lactam De-Labeling: From Bedside Challenge to Long-Term Follow Up.

Saved in:

Bibliographic Details
Title:	The Feasibility and Applicability of Pediatric Inpatient Beta Lactam De-Labeling: From Bedside Challenge to Long-Term Follow Up.
Authors:	Paret M; Department of Pediatrics, Shamir Medical Center, Zerifin, Israel.; Department of Medical and Health Science, Tel-Aviv University, Tel-Aviv, Israel. michalparet@gmail.com., Komargodski R; Department of Pharmacy, Shamir Medical Center, Zerifin, Israel.; School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., London B; Department of Pediatrics, Shamir Medical Center, Zerifin, Israel.; Department of Medical and Health Science, Tel-Aviv University, Tel-Aviv, Israel., Paz H; Department of Pediatrics, Shamir Medical Center, Zerifin, Israel.; Department of Medical and Health Science, Tel-Aviv University, Tel-Aviv, Israel., Rigbi NE; Department of Medical and Health Science, Tel-Aviv University, Tel-Aviv, Israel.; The Institute of Allergy, Immunology and Pediatric Pulmonology, Shamir Medical Center, Zerifin, Israel.; Allergy and Immunology Unit, Assuta Ashdod Medical Center, Ashdod, Israel.; Faculty of Health Science, Ben Gurion University, Be'er Sheva, Israel.
Source:	Infection & chemotherapy [Infect Chemother] 2026 Mar; Vol. 58 (1), pp. 29-38. Date of Electronic Publication: 2025 Nov 13.
Publication Type:	Journal Article
Journal Info:	Publisher: Korean Society of Infectious Diseases, Korean Society for Chemotherapy Country of Publication: Korea (South) NLM ID: 101531537 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2093-2340 (Print) Linking ISSN: 15988112 NLM ISO Abbreviation: Infect Chemother Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2093-2340
DOI:	10.3947/ic.2025.0077